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Summary In order to determine the clinical value of CEA detection in large bowel cancer tissue the patterns
rather than the intensity of immunoreactivity of CEA reactive antibodies were analyzed in 312 large bowel
cancer patients especially in relation to patient survival. CEA immunoreactivity appeared to be
distinguishable into a predominantly apical/cytoplasmic and a predominantly membranous pattern.
Twenty-four (7.7%) tumours were found to be CEA negative or only focally positive. Two hundred and
eighty-three (90.7%) of the carcinomas showed a predominantly apical/cytoplasmic immunoreactivity pattern,
whereas 5 (1.6%) of the tumours revealed mostly membranous CEA immunoreactivity. CEA negative or
focally positive carcinomas and CEA positive tumours with membranous immunoreactivity were significantly
more often observed in the group of poorly differentiated carcinomas (P>0.001), but showed no significant
correlation with stage of tumour extension (P=0.11). Also, these carcinomas demonstrated a more aggressive
course in patients compared to CEA positive tumours with an apical/cytoplasmic CEA expression pattern.
We, therefore, conclude that determination of the pattern of CEA immunoreactivity in large bowel cancer
tissue may enable the detection of subgroups ofpatients with a poor prognosis.
Preoperative estimation of plasma levels of carcino-
embryonic antigen (CEA) in patients with
colorectal cancer has an established role as an
independent prognostic parameter and as a
parameter for detection and monitoring of
recurrent disease (Anonymous, NIH Concensus
Development Conference Statement, 1981).
CEA tissue immunoi'reactivity, in contrast, is
considered to be of less significance. Its value as yet
has been limited to the identification of a small
group of patients without CEA expression in
tumour cells. These carcinomas are usually poorly
differentiated and monitoring of plasma CEA levels
during follow up is not useful in these cases (Goslin
et al., 1981).
However, there are indications that both the
presence of CEA in tissue (Goldenberg et al., 1976)
and its localization within the cell (Ahnen, et al.,
1982; Hamada et al., 1985) are related to the
histological grade of colorectal tumours and thus
could be of potential prognostic value.
We therefore studied the immunoreactivity
patterns at the cellular level of one polyclonal anti
CEA antibody and one CEA specific monoclonal
antibody on histological specimens of 312 and 231
colorectal carcinoma patients respectively. The
CEA staining patterns were correlated with stage
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and grade of the carcinomas as well as with data
on patient survival.
Materials and methods
Patients
The material for this study was obtained as part of
a prospective multicentre trial comparing the no-
touch isolation technique of Turnbull et al. (1967)
with a conventional surgical technique. History,
liver function tests, tumour localization and type of
operation were recorded. Follow-up to determine
disease free interval was performed every 3/6
months according to a strict schedule. Mean
duration of follow-up was 51.9 months (range,
44.1-60.0 months). Survival was corrected for non
disease related death.
Histological specimen
All sections and paraffin blocks available of the
specimens including regional lymph nodes (ranging
from 2 to 15 per case) were collected from the
different centres participating in the trial and were
reviewed regarding stage, histological grade and
CEA immunoreactivity according to the following
criteria:
Stage
A method of staging derived from the Dukes
classification was used (Turnbull et al., 1967).
(a) tumour confined to the bowel wall;
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(b) tumour extension into the pericolic fat;
(c) both a or b with regional lymphnode
metastases;
(d) infiltrative growth in adjacent organs or distant
metastases.
Grading
The degree of differentiation was assessed
according to a modification of the criteria
employed by Blenkinsopp et al. (1981): well
differentiated (tumours entirely consisting of
glandular formation having up to two layers of
lining cells with preserved nuclear polarity), poorly
differentiated (tumours with >10% of a solid
growth pattern), moderately differentiated (tumours
covering spectrum between well and poorly
differentiated) and undifferentiated (no glandular
structures). At least two different sections of each
tumour and grading was based on the least
differentiated areas observed.
Antibodies
A conventional rabbit anti CEA antibody was
purchased from Dakoimmunoglobulin
(Copenhagen, Denmark). The characteristics of the
monoclonal CEA reactive antibody (Parlam 1)
produced in our institution have been described in
detail elsewhere (Verstijnen et al., 1986).
Immunohistochemistry
One block of formalin fixed and paraffin embedded
tumour tissue preferably containing normal
adjacent mucosa was used for immunohisto-
chemistry. Immunostaining with the conventional
antibody was performed with the unlabelled peroxi-
dase-antiperoxidase procedure, whereas the mono-
clonal antibody Parlam 1 was applied in an indirect
peroxidase labelling technique using rabbit anti-
mouse Ig as a second layer as described by Arends
et al. (1983) and Verstijnen et al. (1986).
Scoring ofimmunoreactivity
The pattern of immunoreactivity of the CEA
reactive antibodies was scored semiquantitatively as
follows: Tumours were classified as negative if
<80% of the individual tumour cells displayed
immunoreactivity. Tumours were classified as
positive if >80% of the tumour cells showed CEA
expression. In addition with regard to CEA
localization within the individual tumour cell a
distinction was made in tumours with more than
80% apical and/or cytoplasmic staining pattern
(Figure la) and in tumours with immunoreactivity
confined to the cell membranes in >80% of the
tumour cells (Figure lb).
....~~~~~~~B
Figure 1 CEA immunoreactivity patterns in
colorectal carcinoma. (a) colonic carcinoma with a
positive, apical staining pattern (b) colonic carcinoma
with a predominant membranous staining pattern
(immunoperoxidase CEA, x 250).
Statisticalanalysis
All patients data were stored on a computer. A raw
chi-square analysis for association was used for
interpretation of the cross tabulations between
immunoreactivity pattem and histological grading
or staging. The calculations were made with the aid
of SPSS (Statistical Package for Social Sciences).
Life tables were computed with the BMDP
program (Biomedical Computer Program P-series).
They are based on the product limit method of
individual survival times (Kaplan-Meier).
Calculations of the significance of observed
differences were made using the logrank test
(Mantel Cox) and the generalized Wilcoxon test
(Breslow).
Results
CEA immunoreactivity patterns
Twenty-four out of 312 (7.7%) large bowel
carcinomas showed no or only focal CEA
immunoreactivity. In the remainder of the cases
marked CEA expression was observed in either
an apical/cytoplasmic or membranous pattern. TheCEA IN LARGE BOWEL CANCER TISSUE 411
apical and cytoplasmic staining patterns gradually
merged, whereas a predominant membranous CEA
immunoreactivity could be easily distinguished in 5
cases (1.6%). No striking difference was noticed in
the distribution or localization pattern of CEA as
detected by the polyclonal anti CEA antiserum and
the monoclonal antibody Parlam 1, which was
employed in a more restricted number of cases
(231).
CEA immunoreactivity patterns in relation to stage
andgrade
In Table I the immunoreactivity patterns ofthe CEA
reactive monoclonal antibody Parlam 1 and
polyvalent anti CEA antibody are compiled in
relation to stage of tumour extension and
histological grade.
CEA-negative carcinomas predominated in the
more advanced stages of tumour extension and the
group of poorly differentiated tumours (P=0.11,
P<0.001, respectively).
Tumours with membranous CEA expression
tended to occur mainly in the advanced stages of
tumour extension (P=0.1 1) and the group ofpoorly
differentiated tumours (P<0.001).
CEA immunoreactivity patterns in relation to patient
survival
In Figure 2 patient survival is shown in relation
to CEA positive and CEA negative tumours.
Patients with CEA negative tumours demonstrate a
poor survival in comparison with patients with
CEA positive carcinomas (Wilcoxon P<0.02;
Mantel/Cox P<0.04).
Figure 3 illustrates the difference in survival
between patients with tumours demonstrating an
apical/cytoplasmic immunoreactivity pattern and
tumours with membranous CEA expression.
Patients from the latter group showed a markedly
poorer survival than patients with
apical/cytoplasmic positive carcinomas (Wilcoxon
P<0.001; Mantel/Cox P<0.001).
Discussion
The majority of large bowel carcinomas express
CEA and a correlation between CEA
immunoreactivity and histological grade has been
repeatedly recorded in the literature (Denk
et al., 1972; Huitric et al., 1976; Goldenberg
et al., 1976; O'Brien et al., 1981). Whereas well
Table I CEA immunoreactivity patterns in relation to stage and grade. Figures indicate absolute numbers ofcases.
Dukes' stage
Antigen A B C D Total
Polyvalent anti CEA negative 3 (12.5%) 7 (29.2%) 12 (50.0%) 2 (8.3%) 24
apical/cytoplasmic 68 (24.5%) 112 (38.3%) 79 (28.8%) 24 (8.4%) 283
membranous 0 (0.0%) 1 (20.0% 3 (60.0%) 1 (20.0%) 5
71 120 94 27 312 P=0.17
Parlam 1 mab negative 3 (13.6%) 6 (27.3%) 11 (50.0%) 2 (9.1%) 22
apical/cytoplasmic 49 (25.1%) 89 (39.7%) 55 (28.7%) 13 (6.5%) 206
membranous 0 (0.0%) 1 (33.3%) 2 (66.6%) 0 (0.0%) 3
52 96 68 15 231 P=0.11
Moderately Poorly
Antisera Well-differentiated differentiated differentiated Total
Polyvalent anti CEA negative 0 (0.0%) 11 (47.8%) 12 (52.2%) 23
apical/cytoplasmic 30 (11.2%) 235 (83.1%) 16 (5.8%) 281
membranous 0 (0.0%) 1 (33.3%) 2 (66.6%) 3
30 247 30 307 P<0.001
Parlam 1 mab negative 0 (0.0%) 10 (47.6%) 11 (52.4%) 21
apical/cytoplasmic 20 (10.6%) 178 (86.2%) 6 (3.2%) 204
membranous 0 (0.0%) 0 (0.0%) 2 (100.0%) 2
20 188 19 227 P<0.001412 T. WIGGERS et al.
Survival of patients with CEA positive versus negative tumours
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Figure 2 Survival corrected for non-disease related death of patients with CEA negative tumours (.) and
CEA positive tumours (---) as detected with polyvalent anti CEA (Wilcoxon P<0.02; Mantel/Cox
P<0.04).
Survival of patients with tumours of an apical/cytoplasmic versus membranous
CEA expression pattern
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Figure 3 Survival corrected for non disease related death of patients with predominantly apical/cytoplasmic
(----) and membranous ( ) staining patterns as detected with mab Parlam 1 (Wilcoxon P<0.001;
Mantel/Cox P<0.001).CEA IN LARGE BOWEL CANCER TISSUE 413
differentiated carcinomas generally demonstrate
strong CEA expression, poorly differentiated and
undifferentiated neoplasms may be devoid of the
antigen. In this context CEA negative tumours are
thought to behave more aggressively. This notion
has been confirmed in our study correlating the
CEA expression status directly to data on survival
in a large series of patients with long well
documented follow-up periods. Rognum et al.
(1982), however, were not able to show a
correlation between the intensity of CEA expression
and differentiation of large bowel tumours.
Moreover plasma CEA levels do not seem to
correspond with the intensity of CEA immuno-
reactivity in individual patients (Lewis & Keep,
1981). Although for these reasons the clinical
relevance of tissue CEA detection remained limited,
there are indications that the role of CEA tissue
immunoreactivltv in the diagnosis and management
of colorectal canccr patients needs reconsideration.
Most workers focussed on the intensity of CEA
immunoreactivity and little attention so far has
been paid to the pattern of CEA localization in the
large bowel cancer cell. Yet, the pattern of CEA
expression may be more relevant to study the
biological behaviour of colorectal carcinomas than
the intensity of the immunoreaction, which is
variable and depends on several factors, such as
tissue preservation and the affinity of the antibodies
used. Ahnen et al. (1982) observed a polar
distribution of CEA using immunoelectronmicro-
scopy in the microvilli of the apical plasma-
membranes of normal colonic epithelium, whereas
in neoplastic epithelium a gradual loss of polarity
occurred in relation to the grade of anaplasia.
Poorly differentiated tumours demonstrated CEA
over the entire cell surface. These observations
suggest that the pattern of CEA immunoreactivity
described in terms of apical/cytoplasmic or
membranous localization in tumour cells may be
related to histological grade and thus may be of
prognostic significance. Hamada et al. (1985)
indeed showed that large bowel carcinomas with
CEA expression along the basolateral cell surface
generally belong to the moderately and poorly
differentiated group of tumours, but did not
provide data on how this was correlated with
patient survival.
Our study demonstrates that the subdivision of
CEA expression into apical/cytoplasmic and
membranous patterns at the light microscope level
is feasible and confirms that tumours with a pattern
ofmembranous expression predominate in the more
anaplastic histological grades. Moreover,
carcinomas with a membranous expression pattern
were shown to behave more aggressively in patients
than tumours with an apical/cytoplasmic pattern of
immunoreactivity.
In the application of rigorous criteria for the
classification of tumours into patterns of CEA
expression, however, we were unable to distinguish
between apical and cytoplasmic staining patterns
and therefore these had to be lumped together.
Moreover, only very few tumours with a
predominantly membranous pattern of expression
could be discerned, resulting in two imbalanced
groups, which may introduce a bias in the statistical
evaluation of the data. This situation, which
drastically restricts the practical relevance of our
observations, appeared to be due to considerable
intra tumour heterogeneity in the pattern of CEA
expression. To pathologists, who have long since
recognized the difficulty of grading large bowel
carcinomas due to intra tumour heterogeneity of
differentiation (Qualheim & Gall, 1975), this is
familiar. Our data therefore illustrate the
practicality of characterizing tumours according
to a feature heterogeneously expressed in relation to
biological behaviour, which represents the outcome
of the interrelation and interaction of several clones
differeing in this feature. Nevertheless, our study
confirms the observations of Ahnen et al. (1982)
and Hamada et al. (1985) in that the pattern of
CEA expression closely reflects the degree of
differentiation of individual large bowel cancer cells
and in addition demonstrates that tumours
displaying a rather homogeneous membranous
pattern of CEA expression behave aggresively.
Further studies on the correlation between the
pattern of CEA expression and clinical course in
large bowel cancer patients applying other criteria
for the classification of these patterns are therefore
warranted. Also, in a multivariate analysis of
prognostic factors in colorectal carcinoma the
pattern of CEA expression should be included.
We gratefully acknowledge the technical assistance of
Miss M. Pijls and Miss B. Engelen and preparation of the
manuscript by Mrs M. Rikers, Miss M. Reijnders and
Mrs M. van Puyenbroek.
This study was supported by a grant of the Netherlands
Cancer Foundation KWF (grant number RUL 82-1).
References
AHNEN, D.J., NAKANE, P.K. & BROWN, N.R. (1982).
Ultrastructural localization of carcinoembryonic
antigen in normal intestine and colon cancer. Cancer,
49, 2077.
ANONYMOUS, (1981). Carcinoembryonic antigen: its role
as a marker in the management of cancer - National
Institutes of Health Consensus Development
Conference Statement. Cancer Res., 41, 2017.414 T. WIGGERS et al.
ARENDS, J.W., VERSTIJNEN, C., BOSMAN, F.T., HILGERS, J.
& STEPLEWSKI, Z. (1983). Distribution of monoclonal
antibody-defined monosialoganglioside in normal and
cancerous human tissues: an immunoperoxidase study.
Hybridoma, 2, 219.
BLENKINSOPP, W.K., STEWART-BROWN, S., BLESOVSKY,
L., KEARNEY, G. & FIELDING, L.P. (1981).
Histopathology reporting in large bowel cancer. J.
Clin. Pathol., 34, 509.
DENK, H., TAPPEINER, G., ECKENSTORFER, R.,
HOLZNER, H.J. (1972). Carcinoembryonic antigen
(CEA) in gastrointestinal and extragastrointestinal
tumours and its relationship to tumour-cell
differentiation. Int. J. Cancer, 10, 262.
GOLDENBERG, D.M., SHARKEY, R.M. & PRIMUS, F.J.
(1976). Carcinoembryonic antigen in histopathology:
Immunoperoxidase staining of conventional tissue
sections. J. Natl Cancer Inst., 57, 11.
GOSLIN, T., O'BRIEN, M.J., STEELE, G. & 4 others (1981).
Correlation of plasma CEA and CEA tissue staining in
poorly differentiated colorectal cancer. Am. J. Med., 71,
246.
HAMADA, Y., YAMAMURA, M., HIOKI, K., YAMAMOTO,
M., NAGURA, H. & WATANABE, K. (1985).
Immunohistochemical study of carcinoembryonic
antigen in patients with colorectal cancer. Cancer, 55,
136.
HUITRIC, E., LAUMONIER, R., BURTIN, P., VON KLEIST,
S. & CHAVANEL, G. (1976). An optical and
ultrastructural study of the localization of
carcinoembryonic antigen (CEA) in normal and
cancerous human rectocolonic mucosa. Lab. Invest.,
34, 97.
LEWIS, J.C.M. & KEEP, P.A. (1981). Relationships of serum
CEA levels to tumour size and CEA content in nude
mice having colonic tumour xenografts. Br. J. Cancer,
44, 381.
O'BRIEN, M.J., ZAMCHECK, N., BURKE, B., KIRKHAM,
S.E., SARAVIS, C.A. & GOTTLIEB, L.S. (1981). Immuno-
cytochemical localization of carcinoembryonic antigen
in benign and malignant colorectal tissue. Am. J. Clin.
Pathol., 75, 283.
QUALHEIM, R.E. & GALL, E.A. (1975). Is histological
grading of colon carcinoma a valid procedure? Arch.
Pathol., 56, 466.
ROGNUM, T.O., THORUD, E., ELGJO, D., BRANDTZAEG,
P., ORJASAETER, J.H. & NYGAARD, K. (1982). Large
bowel carcinomas with different ploidy, related to
secretory component, IgA, and CEA in epithelium and
plasma. Br. J. Cancer, 45, 921.
TURNBULL, R.B. JR., KYLE, K., WATSON, F.R. & SPRATT,
J. (1967). Cancer of the colon: the influence of the no-
touch isolation technique on survival rates. Ann. Surg.,
166, 420.
VERSTIJNEN, C., ARENDS, J.W., MOERKERK, P.M.,
HILGERS, J. & BOSMAN, F.T. (1986). CEA-specificity
of CEA-reactive monoclonal antibodies. Immuno-
chemical and immunocytochemical studies. Anti Cancer
Res., 6, 97.